Gallbladder carcinoma: prognostic factors and therapeutic options

被引:26
|
作者
Thorsten Oliver Goetze [1 ]
机构
[1] Institut of Clinical Cancer Research,UCT-University Cancer Center Frankfurt
关键词
Gallbladder carcinoma; Stage-adjusted therapy; Radical cholecystectomy; Gallbladder polyps; Cholecystitis; Gallstones; Laparoscopic cholecystectomy;
D O I
暂无
中图分类号
R735.8 [胆囊、胆道肿瘤];
学科分类号
100214 ;
摘要
The outcome of gallbladder carcinoma is poor,and the overall 5-year survival rate is less than 5%. In early-stage disease,a 5-year survival rate up to 75% can be achieved if stage-adjusted therapy is performed. There is wide geographic variability in the frequency of gallbladder carcinoma,which can only be explained by an interaction between genetic factors and their alteration. Gallstones and chronic cholecystitis are important risk factors in the formation of gallbladder malignancies. Factors such as chronic bacterial infection,primary sclerosing cholangitis,an anomalous junction of the pancreaticobiliary duct,and several types of gallbladder polyps are associated with a higher risk of gallbladder cancer. There is also an interesting correlation between risk factors and the histological type of cancer. However,despite theoretical risk factors,only a third of gallbladder carcinomas are recognized preoperatively. In most patients,the tumor is diagnosed by the pathologist after a routine cholecystectomy for a benign disease and is termed ‘‘incidental or occult gallbladder carcinoma’’(IGBC). A cholecystectomy is performed frequently due to the minimal invasiveness of the laparoscopic technique. Therefore,the postoperative diagnosis of potentially curable early-stage disease is more frequent. A second radical re-resection to complete a radical cholecystectomy is required for several IGBCs. However,the literature and guidelines used in different countries differ regarding the radicality or T-stage criteria for performing a radical cholecystectomy. The NCCN guidelines and data from the German registry(GR),which records the largest number of incidental gallbladder carcinomas in Europe,indicate that carcinomas infiltrating the muscularis propria or beyond require radical surgery. According to GR data and current literature,a wedge resection with a combined dissection of the lymph nodes of the hepatoduodenal ligament is adequate for T1 b and T2 carcinomas. The reason for a radical cholecystectomy after simple CE in a formally R0 situation is either occult invasion or hepatic spread with unknown lymphogenic dissemination. Unfortunately,there are diverse interpretations and practices regarding stageadjusted therapy for gallbladder carcinoma. The current data suggest that more radical therapy is warranted.
引用
收藏
页码:12211 / 12217
页数:7
相关论文
共 50 条
  • [21] Prognostic Factors of Patients with Advanced Gallbladder Carcinoma Following Aggressive Surgical Resection
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Nakashima, Akira
    Kondo, Naru
    Sakabe, Ryutaro
    Kobayashi, Hironori
    Sueda, Taijiro
    JOURNAL OF GASTROINTESTINAL SURGERY, 2011, 15 (06) : 1007 - 1016
  • [22] Prognostic Factors of Patients with Advanced Gallbladder Carcinoma Following Aggressive Surgical Resection
    Yoshiaki Murakami
    Kenichiro Uemura
    Takeshi Sudo
    Yasushi Hashimoto
    Akira Nakashima
    Naru Kondo
    Ryutaro Sakabe
    Hironori Kobayashi
    Taijiro Sueda
    Journal of Gastrointestinal Surgery, 2011, 15 : 1007 - 1016
  • [23] Molecular prognostic markers in gallbladder carcinoma
    Jagannath, Palepu
    Callery, Mark
    HPB, 2012, 14 (09) : 571 - 572
  • [24] Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin
    Min su You
    Ji Kon Ryu
    Young Hoon Choi
    Jin Ho Choi
    Gunn Huh
    Woo Hyun Paik
    Sang Hyub Lee
    Yong-Tae Kim
    BMC Cancer, 19
  • [25] THERAPEUTIC OUTCOMES AND PROGNOSTIC FACTORS IN UNRESECTABLE GALLBLADDER CANCER TREATED WITH GEMCITABINE PLUS CISPLATIN
    You, Min Su
    Ryu, Ji Kon
    Choi, Young Hoon
    Shin, Bang-sup
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2018, 154 (06) : S953 - S953
  • [26] Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin
    You, Min Su
    Ryu, Ji Kon
    Choi, Young Hoon
    Choi, Jin Ho
    Huh, Gunn
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    BMC CANCER, 2019, 19 (1)
  • [27] ENDOMETRIAL CARCINOMA - PATHOLOGICAL FACTORS OF THERAPEUTIC AND PROGNOSTIC-SIGNIFICANCE
    SIDAWY, MK
    SILVERBERG, SG
    PATHOLOGY ANNUAL, 1992, 27 : 153 - 185
  • [28] Carcinoma of the uterine cervix: epidemiology, prognostic factors, therapeutic modalities
    Pereira, R
    Renard, A
    Boulbair, F
    Touboul, E
    Lefranc, JP
    BULLETIN DU CANCER, 1998, : 25 - 36
  • [29] Prognostic Factors for Operated Gallbladder Cancer
    Bala Basak Oven Ustaalioglu
    Ahmet Bilici
    Mesut Seker
    Umut Kefeli
    Dincer Aydin
    Serkan Celik
    Tarik Demir
    Burcak Erkol
    Journal of Gastrointestinal Cancer, 2019, 50 : 451 - 457
  • [30] The prognostic factors for operated gallbladder cancer
    Basak, Oven Ustaalioglu Bala
    Ahmet, Bilici
    Mesut, Seker
    Umut, Kefeli
    Dincer, Aydin
    ANNALS OF ONCOLOGY, 2017, 28